The status, limitation and improvement of adoptive cellular immunotherapy in advanced urologic malignancies.

Abstract

In recent years, immunotherapy has been gradually established as the fourth frequently adopted antitumor therapy, following surgery, chemotherapy and radiotherapy, for advanced urologic malignancies with an improved understanding of theoretical basis, such as molecular biology and immunology. Thereinto, adoptive cellular immunotherapy (ACI) has become one… (More)
DOI: 10.3978/j.issn.1000-9604.2014.12.15

Topics

1 Figure or Table

Cite this paper

@article{Shi2015TheSL, title={The status, limitation and improvement of adoptive cellular immunotherapy in advanced urologic malignancies.}, author={Haoqing Shi and Xiangjie Qi and Bin Ma and Yanwei Cao and Lina Wang and Lijiang Sun and Haitao Niu}, journal={Chinese journal of cancer research = Chung-kuo yen cheng yen chiu}, year={2015}, volume={27 2}, pages={128-37} }